Verve Therapeutics
VERV
#7271
Rank
ยฃ0.28 B
Marketcap
ยฃ3.20
Share price
-9.52%
Change (1 day)
-68.61%
Change (1 year)

Revenue for Verve Therapeutics (VERV)

Revenue in 2024 (TTM): ยฃ25.35 Million

According to Verve Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ25.02 Million. an increase over the revenue in the year 2023 that were of ยฃ9.22 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verve Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 ยฃ25.76 M179.16%
2023 ยฃ9.22 M475.24%
2022 ยฃ1.6 M
2021 N/A
2020 N/A